Master, Bachelor and Erasmus projects
Master, Bachelor and Erasmus projects completed at the Division of Affinity Proteomics.
| Student | Year | Project |
|---|---|---|
| Tilde Nordlander | 2025 | Differentiating Disease States: An Analysis of Antibody Profiles in a Tuberculosis Cohort |
| Rebecca Randleff | 2025 | Plasma proteins associated with mental disorders |
| Kristian Pelligra | 2025 | The effect of ventricle volumes on CSF protein level variability in Alzheimer’s disease |
| Metta Berenpas | 2025 | Affinity proteomics application to study autoimmune diseases |
| Kathrina Bölz | 2025 | Multiplexed immunoassays for immune monitoring |
| Anna Gardell | 2024 | Dried Blood Spot Measurements of Lung-Specific Proteins – A BAMSE Cohort Study |
| Edvin Ljungqvist | 2024 | Longitudinal Multi-Disease Serology Profiling |
| Hampus Hagelin | 2024 | Computational analysis of the circulating proteome in breast cancer |
| Maria Aspenberg | 2024 | Profiling of Autoimmune Autoantibody Biomarkers in Systemic Sclerosis and Vasculitis |
| Nina de Vita | 2024 | Protein profiling within amyotrophic lateral sclerosis |
| Axelina Schmidt | 2023 | Exploring IGF interactions in the context of amyotrophic lateral sclerosis |
| Ionela Madac | 2023 | Microsampling and point of care devices in biomarkers monitoring |
| William Stauch | 2023 | Analysis of fertility-related proteins in dried blood spot samples |
| Amelie Vogt | 2022 | Versatile immunoassays for biomarker quantification in home-samples blood |
| Federica Ress | 2022 | Detection and exploration of the systemic sclerosis autoantibody repertoire by data-driven approaches |
| Sarah Andersson | 2022 | Profiling host proteins in the envelope of SARS-CoV-2 viral particles |
| Alfred Kedhammar | 2021 | Investigating the autoimmunity profiles of Covid-19 patients |
| Emmie Pohjanen | 2021 | Profiling the autoantibody repertoire in systemic sclerosis |
| Hugo Hammar | 2021 | Development of ultra-sensitive immunoassays for low abundance biomarkers in human plasma |
| Paul Boulouednine | 2021 | Proteomic analysis of enveloped viruses |
| Vincent Albrecht | 2021 | A proteomics journey on methods and approaches to tackle COVID-19 |
| Jamil Yousef | 2020 | Development of Sandwich Assays for Potential Protein Biomarkers in Neurodegenerative Diseases |
| Leo Dahl | 2020 | Stratification of breast cancer patients by applying advanced bioinformatics methods to plasma proteomics data |
| Lovisa Skoglund | 2020 | Method development for enrichment of autoantibodies from human plasma |
| Sofia Kagioglu | 2020 | Development of a bead-based assay to detect intact viral particles. |
| Svenja Wingerter | 2020 | Advanced glycopeptide profiling for targeted SARS-CoV-2 serology |
| Julius Lautenbach | 2019 | Analysis of protein interaction in plasma derived from network analysis |
| Aikaterini Kaltsa | 2018 | GAP43 as a potential biomarker for neurodegeneration |
| Annika Anderson | 2018 | Parallel Reaction Monitoring (PRM) mass spectrometry for protein biomarkers verification in neurodegenerative disorders |
| August Jernbom Falk | 2018 | Exploring novel autoantibodies within Alzheimer's disease |
| Pablo San Segundo Acosta | 2018 | Profiling of Alzheimer’s Disease Serum for the Identification of Autoantibody Biomarkers |
| Philip Andersson | 2018 | Microarray-Based Systems for the Analysis of Cancer Associated Autoantibodies |
| Jennie Olofsson | 2017 | Autoantibody profiling in ALS plasma |
| Matilda Dale | 2017 | Autoimmunity profiling of auto-reactive antibodies in plasma of patients with pancreatic diseases |
| Annika Bendes | 2016 | Protein profiling of cell lysate using suspension bead arrays |
| Francis Cavallo | 2016 | Autoantibody profiling in schizophrenia |
| Isabelle Lilja | 2016 | Autoantibody profiling: a prognostic tool for progression of COPD in healthy heavy smokers |
| Lucas Bremer | 2016 | Designing and characterising a dual format antigen protein microarray for autoimmune profiling |
| Marina Ioannou | 2016 | Translational proteomics for protein biomarkers in blood: Linking affinity based assays with mass spectrometry |
| Sofia Bergström | 2016 | Kidney disease-related protein profiling |
| Helene Bordelet | 2015 | Hydrogel nanoparticles to enhance quantification of low abundant, low molecular weight proteins in plasma. |
| Kristin Stirm | 2015 | Affinity Proteomics application of the multiplexed immunoassay DigiWest for the analysis of ovarian carcinoma tissue and plasma |
| Tea Dodig-Crnkovic | 2015 | Proteomic profiling of sera in elderly twins |
| Cecilia Hellström | 2014 | Reverse phase protein array for serum and plasma profiling |
| Philippa Reuterswärd | 2013 | Development of dual capture assays for antibody suspension bead arrays |
| Arash Zandian | 2012 | A pilot study using antigen microarrays to identify putative autoimmunity targets in psychiatric disorders |
| Atefeh Mohsenchian | 2012 | Biomarker discovery in ALS by affinity proteomics |
| David Solomon | 2012 | Discovery and verification of osteoporosis associated plasma proteins |
| Maria Mikus | 2012 | Discovery of biomarkers for drug-induced liver injury using affinity proteomics |
| Nick Nyaiesh | 2012 | Affinity profiling of candidate serological protein markers within malignant melanoma |